PremiumThe FlyGoodRx appoints interim CFO as Karsten Voermann resigns GoodRx price target lowered to $4.25 from $4.50 at BofA GoodRx Holdings CFO Resigns, Interim CFO Appointed PremiumCompany AnnouncementsGoodRx Holdings Appoints Wendy Barnes as CEO GE Vernova initiated, Merck upgraded: Wall Street’s top analyst calls GoodRx initiated with a Neutral at Mizuho PremiumCompany AnnouncementsGoodRx Holdings Reports Strong Q3 2024 Performance GoodRx reports Q3 adjusted EPS 8c, consensus 9c GoodRx sees Q4 revenue ~$200M, consensus $206.25M